Skip to main content

PhaseBio Pharmaceuticals Inc

PHASDelisted Dec 21, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001169245

PhaseBio Pharmaceuticals Inc was delisted on Dec 21, 2022; its insiders filed their last Form 4 on May 19, 2023; 39 institutions reported holding it in 13F filings for Q3 2022, worth $3.90M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in PhaseBio Pharmaceuticals Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

PHAS is no longer listed, so this page shows Q3 2022. 13F filings for later quarters list far fewer holders.

Institutional holders
39
−11 vs. Q2 2022
Shares held
22.2M
−1.25M (−5.4%) vs. Q2 2022
Total value
$3.90M
−$10.2M (−72.3%) vs. Q2 2022
New holders
1
6 more added
Sold out
12
12 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PHAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 39 institutions
Q1 2021: 62 institutionsQ2 2021: 56 institutionsQ3 2021: 62 institutionsQ4 2021: 52 institutionsQ1 2022: 57 institutionsQ2 2022: 50 institutionsQ3 2022: 39 institutionsQ4 2022: 5 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2022: $3.90M
Q1 2021: $110.3MQ2 2021: $113.3MQ3 2021: $95.9MQ4 2021: $73.5MQ1 2022: $38.8MQ2 2022: $14.1MQ3 2022: $3.90MQ4 2022: $15.6KQ1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PHAS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20225$15.6K
Q3 202239$3.90M
Q2 202250$14.1M
Q1 202257$38.8M
Q4 202152$73.5M
Q3 202162$95.9M
Q2 202156$113.3M
Q1 202162$110.3M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding PhaseBio Pharmaceuticals Inc; share changes are against Q2 2022.

Institutions holding PHAS in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
NEA Management Company, LLC6,643,702$1.17M0.06%00.0%Unchanged
Avidity Partners Management LP4,361,365$768.0K0.02%−43,635−1.0%Reduced
Rock Springs Capital Management LP2,719,074$479.0K0.01%−55,795−2.0%Reduced
MAI Capital Management2,307,534$406.0K0.01%+598,430+35.0%Added
Vanguard Group Inc1,808,098$318.0K0.00%00.0%Unchanged
Johnson & Johnson1,607,044$283.0K0.08%00.0%Unchanged
BlackRock Inc.665,563$116.0K0.00%−18,641−2.7%Reduced
DAFNA Capital Management LLC321,856$57.0K0.02%−56,755−15.0%Reduced
Geode Capital Management, LLC320,642$56.0K0.00%00.0%Unchanged
Platform Technology Partners231,900$41.0K0.02%−11,000−4.5%Reduced
Bridgeway Capital Management, LLC201,600$35.0K0.00%+75,000+59.2%Added
Resources Investment Advisors, LLC.171,150$30.0K0.00%+155,000+959.8%Added
Acadian Asset Management LLC172,958$29.0K0.00%−99,812−36.6%Reduced
Jane Street Group, LLC110,661$19.0K0.00%−2,007−1.8%Reduced
Morgan Stanley95,763$17.0K0.00%−11,003−10.3%Reduced
State Street Corp91,850$16.0K0.00%00.0%Unchanged
Snowden Capital Advisors LLC60,800$10.0K0.00%00.0%Unchanged
Northern Trust Corp58,119$10.0K0.00%00.0%Unchanged
Northeast Financial Consultants Inc37,760$7.00K0.00%00.0%Unchanged
United Bank37,400$7.00K0.00%+10,500+39.0%Added
Blair William & Co35,696$6.00K0.00%00.0%Unchanged
Hamilton Lane Advisors LLC34,208$6.00K0.00%00.0%Unchanged
IPG Investment Advisors LLC28,700$5.05K0.00%−200−0.7%Reduced
Raymond James & Associates15,500$3.00K0.00%00.0%Unchanged
Stifel Financial Corp13,721$2.00K0.00%−425,544−96.9%Reduced
Tower Research Capital LLC (TRC)10,603$2.00K0.00%−14,600−57.9%Reduced
Harbour Investments, Inc.3,600$2.00K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.3,825$1.00K0.00%00.0%Unchanged
TD Waterhouse Canada Inc.850$2110.00%00.0%Unchanged
BNP Paribas Arbitrage, SA79$140.00%00.0%Unchanged
Citigroup Inc100$00.00%−5,900−98.3%Reduced
Wells Fargo & Company1,821$00.00%+14+0.8%Added
Royal Bank of Canada2,185$00.00%+185+9.3%Added
JPMorgan Chase & Co17$00.00%00.0%Unchanged
Bank of America Corp193$00.00%00.0%Unchanged
Barclays PLC197$00.00%00.0%Unchanged
Cutler Group LP1,000$00.00%00.0%Unchanged
Kistler-Tiffany Companies, LLC300$00.00%00.0%Unchanged
Simplex Trading, LLC3,317$00.00%+3,317New
CHI Advisors LLC0$00.00%−750,000−100.0%Sold out
New Legacy Group, LLC0$00.00%−240,575−100.0%Sold out
Marshall Wace, LLP0$00.00%−123,039−100.0%Sold out
Citadel Advisors LLC0$00.00%−107,953−100.0%Sold out
Prudential Financial Inc0$00.00%−44,100−100.0%Sold out
Virtu Financial LLC0$00.00%−31,852−100.0%Sold out
Millennium Management LLC0$00.00%−13,501−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−12,845−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−12,700−100.0%Sold out
UBS Group AG0$00.00%−9,830−100.0%Sold out
Toronto Dominion Bank0$00.00%−4,670−100.0%Sold out
Curi Capital0$00.00%−823−100.0%Sold out